Related Experiment Videos
Myocyte apoptosis in heart failure.
Vanessa P M van Empel1, Anne T A Bertrand, Leo Hofstra
1Hubrecht Laboratory and Interuniversity Cardiology Institute Netherlands, Royal Netherlands Academy of Sciences, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Cardiovascular Research
|May 18, 2005
Summary
Cardiac remodeling leads to heart failure through programmed cell death (apoptosis) in heart muscle cells. Understanding cardiac apoptosis pathways is crucial for developing future heart failure therapies.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Death Research
Background:
- Heart failure is characterized by cardiac remodeling, including chamber enlargement and impaired contractile function.
- Programmed cell death (apoptosis) of cardiac muscle cells is a key factor in heart failure progression.
- Apoptosis is a regulated process, making it a potential therapeutic target if intervened early.
Purpose of the Study:
- To review the apoptotic pathways active in cardiac muscle.
- To discuss therapeutic strategies targeting apoptosis for human heart failure treatment.
Main Methods:
- Literature review of scientific articles on cardiac apoptosis.
- Summary of molecular mechanisms underlying apoptosis in cardiomyocytes.
- Analysis of current and future therapeutic interventions targeting apoptotic pathways.
Main Results:
- Detailed overview of intrinsic and extrinsic apoptotic pathways in the heart.
- Identification of key molecular players and signaling cascades involved in cardiac apoptosis.
- Exploration of pharmacological agents and strategies aimed at modulating apoptosis.
Conclusions:
- Apoptosis is a critical, targetable process in the development of heart failure.
- A comprehensive understanding of cardiac apoptotic pathways is essential for novel therapeutic development.
- Targeting apoptosis holds significant promise for future heart failure treatments.